1Rigante D, Candelli M, Federico G, et al. Predictive factors of renal involvement or relapsing disease in children with Henoch-Schonlein purpura[J]. Rheumatol Int,2005,25(1) :45 - 48
4Hisano S,Matsushita M. Activation of the lectin complement pathway in Henoch-Schordein piarpura nephritis[J]. Am J Kidney Dis, 2005,45(2) :295 - 302
5Shin J I, Park J M, Shin YH, et al. Serum IgA/C3 ratio may be a useful marker of disease activity in severe Henoch-Schonlein nephritis. Nephron Clin Pract, 2005,101 (2) : 72 - 78
6Suzuki D, Toyoda M, Umezono T, et at. Glomerular expression of connective tissue growth factor mRNA in various renal diseases[ J ]. Nephrology, 2003,8(2) :92 - 97
7Nguyen TQ,Tarnow L,Andersen S, et al. Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy[J].Diabetic Care, 2006,29(1) :83 - 88
10Ozkaya O,Sylemezo g- lu O, Gnen S, et al. Renin-angiotensin system gene polymorphisms:association with susceptibility to Henoch- Schonlein purpura and renal involvement [J]. Clin Rheumatol, 2006,25(6) :861 - 865
3STAFFORINI D M,SATOH K,ATKINSON D L,et al. Plateletactivating factor acteylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase [J]. J Clin Invest, 1996,97( 12): 2784 - 2791.
4CHEN A, CHEN W P, SHEU L F, et al. Pathogenesis of IgA nephropathy: in vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretion [J]. J Pathol, 1994, 173(2): 119 - 126.
5BUSTOS C, GONZALEZ E,GONZALEZ-CUADRADO S, et al. Urinary excretion of platelet-activating factor in human and experimental nephrosis [J]. Nephrol Dial Transplant, 1996, 11 (2): 282 - 286.
6Suzuki D,Toyoda M, Umezono T, et al. Glomerular expression of connective tissue growth factor mRNA in various renal diseases [ J ]. Nephrology, 2003,8 ( 2 ) :92 -97.
7Nguyen TQ ,Tarnow L, Andersen S, et al. Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy[J]. Diabetes Care,2006,29 ( 1 ) :83-88.
8Grande JP. Mechanisms of progression of renal damage in lupus nephritis : pathogenesis of renal scarring [ J ]. Lupus, 1998,7 ( 9 ) : 604-610.
2Shenoy M, Oevere MV, Coulthard MG. Treating severe Henoch- schonlein and IgA nephritis with plasmapheresis [J]. Pedatr- Nephrol, 2007,22(8) : 1137.
3Knelt C, Wilelm M. Effect of eradication of Helicobacter py- lori on Platelet recovery in patients with chronic idiopathic thromey topenic prupura[J]. American Journal of Hematolo- gy, 2008, 83(5): 376.
4Jasic M, Subat - Dezulovic M, Nikolic H. HenochSch9 nlein purpura complicated by appendicitis, intussusception and ureteritis [ J ]. Collegium Antropologicum, 2011, 35 ( 1 ) : 197.
